A citation-based method for searching scientific literature

Zhi Li, Sohsuke Yamada, Ying Wu, Ke-Yong Wang, Yun-Peng Liu, Hidetaka Uramoto, Kimitoshi Kohno, Yasuyuki Sasaguri. Oncotarget 2016
Times Cited: 23







List of co-cited articles
78 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival.
Z Li, S Yamada, S Inenaga, T Imamura, Y Wu, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno,[...]. Br J Cancer 2011
55
34

Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Jae-Hyun Park, Toshihiko Nishidate, Kyoko Kijima, Takao Ohashi, Kaoru Takegawa, Tomoko Fujikane, Koichi Hirata, Yusuke Nakamura, Toyomasa Katagiri. Cancer Res 2010
121
34

UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
Nora Berois, Daniel Mazal, Luis Ubillos, Felipe Trajtenberg, André Nicolas, Xavier Sastre-Garau, Henri Magdelenat, Eduardo Osinaga. J Histochem Cytochem 2006
58
30

Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
Jae-Hyun Park, Toyomasa Katagiri, Suyoun Chung, Kyoko Kijima, Yusuke Nakamura. Neoplasia 2011
73
26

Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas.
S Kitada, S Yamada, A Kuma, S Ouchi, T Tasaki, A Nabeshima, H Noguchi, K-Y Wang, S Shimajiri, R Nakano,[...]. Br J Cancer 2013
51
26

Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.
Joana Gomes, Nuno T Marcos, Nora Berois, Eduardo Osinaga, Ana Magalhães, João Pinto-de-Sousa, Raquel Almeida, Fátima Gärtner, Celso A Reis. J Histochem Cytochem 2009
46
21


First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Janette Greenhalgh, Kerry Dwan, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Pooja Jain, John A Green. Cochrane Database Syst Rev 2016
123
17

Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence.
C Gu, T Oyama, T Osaki, J Li, M Takenoyama, H Izumi, K Sugio, K Kohno, K Yasumoto. Br J Cancer 2004
40
17

Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
Eric P Bennett, Ulla Mandel, Henrik Clausen, Thomas A Gerken, Timothy A Fritz, Lawrence A Tabak. Glycobiology 2012
447
17

Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
Leonardo Freire-de-Lima, Kirill Gelfenbeyn, Yao Ding, Ulla Mandel, Henrik Clausen, Kazuko Handa, Sen-Itiroh Hakomori. Proc Natl Acad Sci U S A 2011
85
17


Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
Yunus Emre Tarhan, Taigo Kato, Miran Jang, Yoshimi Haga, Koji Ueda, Yusuke Nakamura, Jae-Hyun Park. Neoplasia 2016
25
17

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Zhi-Qiang Wang, Magdalena Bachvarova, Chantale Morin, Marie Plante, Jean Gregoire, Marie-Claude Renaud, Alexandra Sebastianelli, Dimcho Bachvarov. Oncotarget 2014
60
17

Prognostic utility of glycosyltransferase expression in breast cancer.
Neill Patani, Wen Jiang, Kefah Mokbel. Cancer Genomics Proteomics 2008
32
17

Glycosylation in cancer: mechanisms and clinical implications.
Salomé S Pinho, Celso A Reis. Nat Rev Cancer 2015
17

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
17

Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Joan E Walter, Marjolein A Heuvelmans, Pim A de Jong, Rozemarijn Vliegenthart, Peter M A van Ooijen, Robin B Peters, Kevin Ten Haaf, Uraujh Yousaf-Khan, Carlijn M van der Aalst, Geertruida H de Bock,[...]. Lancet Oncol 2016
118
13


Prognostic significance of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma.
Koji Onitsuka, Kazunori Shibao, Yoshifumi Nakayama, Noritaka Minagawa, Keiji Hirata, Hiroto Izumi, Ken-ichi Matsuo, Naoki Nagata, Kenji Kitazato, Kimitoshi Kohno,[...]. Cancer Sci 2003
32
13

The sweet and sour of cancer: glycans as novel therapeutic targets.
Mark M Fuster, Jeffrey D Esko. Nat Rev Cancer 2005
894
13

GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
Ok-Seon Kwon, Ensel Oh, Jeong-Rak Park, Ji-Seon Lee, Gab-Yong Bae, Jae-Hyung Koo, Hyongbum Kim, Yoon L Choi, Young Soo Choi, Jhingook Kim,[...]. Oncotarget 2015
20
15

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry.
Chen Wu, Xiaodan Guo, Weina Wang, Yun Wang, Yaojun Shan, Bo Zhang, Wenqian Song, Sisi Ma, Jianfeng Ge, Hao Deng,[...]. BMC Cancer 2010
46
13

Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasis.
Friederike Liesche, Alexandra C Kölbl, Matthias Ilmer, Stefan Hutter, Udo Jeschke, Ulrich Andergassen. Mol Med Rep 2016
12
25

N-acetylgalactosaminyltransferases in cancer.
Muhammad Ramzan Manwar Hussain, Daniel C Hoessli, Min Fang. Oncotarget 2016
28
13

Pathology of lung cancer.
William D Travis. Clin Chest Med 2011
302
13

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
8

Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2012
8

Upregulation of long intergenic noncoding RNA 00673 promotes tumor proliferation via LSD1 interaction and repression of NCALD in non-small-cell lung cancer.
Xuefei Shi, Chenhui Ma, Qingqing Zhu, Dongmei Yuan, Ming Sun, Xiaoling Gu, Guannan Wu, Tangfeng Lv, Yong Song. Oncotarget 2016
56
8


The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Jing Liu, Li Wan, Kaihua Lu, Ming Sun, Xuan Pan, Ping Zhang, Binbin Lu, Guojian Liu, Zhaoxia Wang. PLoS One 2015
138
8

miR-339-3p Is a Tumor Suppressor in Melanoma.
Claudia E M Weber, Chonglin Luo, Agnes Hotz-Wagenblatt, Adriane Gardyan, Theresa Kordaß, Tim Holland-Letz, Wolfram Osen, Stefan B Eichmüller. Cancer Res 2016
46
8

MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers.
Pannapa Pinweha, Khanti Rattanapornsompong, Varodom Charoensawan, Sarawut Jitrapakdee. Comput Struct Biotechnol J 2016
49
8

Tumour-cell invasion and migration: diversity and escape mechanisms.
Peter Friedl, Katarina Wolf. Nat Rev Cancer 2003
8

Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
H H Wandall, H Hassan, E Mirgorodskaya, A K Kristensen, P Roepstorff, E P Bennett, P A Nielsen, M A Hollingsworth, J Burchell, J Taylor-Papadimitriou,[...]. J Biol Chem 1997
242
8



Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Yoshikazu Harada, Hiroto Izumi, Hirotsugu Noguchi, Akihiro Kuma, Yuichiro Kawatsu, Tomoko Kimura, Shohei Kitada, Hidetaka Uramoto, Ke-Yong Wang, Yasuyuki Sasaguri,[...]. Tumour Biol 2016
15
13

Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
Yao-Ming Wu, Chiung-Hui Liu, Rey-Heng Hu, Miao-Juei Huang, Jian-Jr Lee, Chi-Hau Chen, John Huang, Hong-Shiee Lai, Po-Huang Lee, Wen-Ming Hsu,[...]. Cancer Res 2011
73
8

Glycosylation defining cancer malignancy: new wine in an old bottle.
Senitiroh Hakomori. Proc Natl Acad Sci U S A 2002
711
8


Glycans in cancer and inflammation--potential for therapeutics and diagnostics.
Danielle H Dube, Carolyn R Bertozzi. Nat Rev Drug Discov 2005
8

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal,[...]. Nat Med 2007
431
8


Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation.
Shin-Yun Liu, Chia-Tung Shun, Kuan-Yu Hung, Hsueh-Fen Juan, Chia-Lang Hsu, Min-Chuan Huang, I-Rue Lai. Oncotarget 2016
25
8

GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Nora Berois, Charles-Henry Gattolliat, Enrique Barrios, Laura Capandeguy, Sétha Douc-Rasy, Dominique Valteau-Couanet, Jean Bénard, Eduardo Osinaga. Clin Chem 2013
33
8

GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Mei-Chun Lin, Miao-Juei Huang, Chiung-Hui Liu, Tsung-Lin Yang, Min-Chuan Huang. Oral Oncol 2014
55
8

Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.
Kazunori Shibao, Hiroto Izumi, Yoshifumi Nakayama, Ryo Ohta, Naoki Nagata, Minoru Nomoto, Ken-ichi Matsuo, Yuji Yamada, Kenji Kitazato, Hideaki Itoh,[...]. Cancer 2002
60
8

Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness.
David J Gill, Keit Min Tham, Joanne Chia, Shyi Chyi Wang, Catharina Steentoft, Henrik Clausen, Emilie A Bard-Chapeau, Frederic A Bard. Proc Natl Acad Sci U S A 2013
124
8

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
Thierry André, Armand de Gramont, Dewi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras-Raballand, Aurelie Scriva, Tamas Hickish, Josep Tabernero, Jean Luc Van Laethem,[...]. J Clin Oncol 2015
303
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.